Related Experiment Videos
Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study
P C Elwood1, S Renaud, D S Sharp
1Medical Research Council Epidemiology Unit, Cardiff, United Kingdom.
Insights
Platelet aggregation, particularly adenosine diphosphate (ADP)-induced aggregation, is linked to a higher risk of past myocardial infarction and ischemic heart disease in men. This finding suggests a potential role for platelet activity in cardiovascular disease development.
Area of Science:
- Cardiovascular Science
- Hematology
- Epidemiology
Background:
- Ischemic heart disease (IHD) remains a leading cause of mortality worldwide.
- Platelet aggregation plays a critical role in thrombotic events underlying IHD.
- Understanding the relationship between platelet function and IHD is crucial for prevention and treatment strategies.
Purpose of the Study:
- To investigate the association between platelet aggregation induced by various agonists and prevalent ischemic heart disease.
- To explore the relationship between platelet aggregation and specific indicators of IHD, including angina and myocardial infarction.
- To assess the impact of confounding factors on the observed associations.
Main Methods:
- Analysis of a large cohort of men (n=1,811) from the Caerphilly Collaborative Heart Disease Study, excluding those on medications affecting platelet function.
- Measurement of platelet aggregation induced by adenosine diphosphate (ADP), collagen, and thrombin in fasting blood samples.
- Statistical analysis to relate platelet aggregation levels to prevalent angina, past myocardial infarction, and electrocardiographic evidence of ischemia.
Main Results:
- Significant associations were found between ADP-induced platelet aggregation (primary and secondary) and past myocardial infarction and electrocardiographic ischemia.
- A strong positive correlation was observed between higher levels of ADP-induced primary platelet aggregation and increased odds of past myocardial infarction.
- Electrocardiographic evidence of ischemia was also significantly related to thrombin-induced platelet aggregation.
Conclusions:
- Platelet aggregation, particularly ADP-induced aggregation, is significantly associated with indicators of past ischemic heart disease in middle-aged men.
- These findings suggest that heightened platelet reactivity may be a contributing factor to the development of ischemic heart disease.
- The observed relationships are unlikely to be solely a consequence of existing ischemic heart disease on platelet function.
Abstract:
The Caerphilly Collaborative Heart Disease Study is based on a large cohort of men (2,398) aged 49-66 years at the time of study. Platelet aggregation induced by collagen, thrombin, and ADP was measured in fasting blood samples and was related to prevalent angina, past myocardial infarction, and electrocardiographic evidence of ischemic heart disease. A number of subjects had taken aspirin, other nonsteroidal anti-inflammatory drugs, or other drugs affecting platelet aggregation 7 days before blood sample collection; after the exclusion of these subjects, data were available for 1,811 men. No relations were demonstrated with angina, but significant relations were shown between past myocardial infarctions and electrocardiographic evidence of ischemia and ADP-induced aggregation (both primary and secondary) and between electrocardiographic evidence of ischemia and thrombin-induced aggregation. The strongest relation indicated more than a twofold increase in the odds of a past myocardial infarction in subjects of the highest fifth of ADP-induced primary platelet aggregation compared with the lowest fifth. No significant relations were detected with collagen-induced aggregation. Accounting for a number of possible confounding factors had a relatively small impact on the relations between platelet aggregation and ischemic heart disease. Other evidence, including the well-established effect of aspirin on reducing the incidence of ischemic heart disease, indicates that the relations we describe are unlikely to be simply an effect of IHD on platelets.